Many studies focusing on the oncogenic functions of c-Fos have demonstrated its involvement in tumor growth through the modulation of Cyclin D1, which is a nuclear regulatory subunit of the cyclin-dependent kinases (CDK)-4 and CDK-6 [65,66,67]. The gene discussed is FOS; the disease is neoplasm.